NeuPath Health (NPTH) Investor presentation summary

Operating scale

• 13 regulated medical facilities in Ontario and Alberta; ~160 healthcare professionals, ~200,000 annual patient visits and 5,000+ referring physicians.

• Community-based care focuses on chronic and musculoskeletal pain; patient satisfaction is rated 4.6+/5 on Google.

Financial and operating performance

• H1 2026 revenue was C$44.7M vs. C$41.1M, up 9%; adjusted EBITDA was C$3.2M vs. C$2.9M, up 8%; 2025 comparison excludes a prior-year one-time payment.

• H1 adjusted EBITDA was 7.2% of revenue.

• Q2 physical capacity utilization was 54% vs. 49% in Q2 YTD 2025; another presentation metric reported Q2 capacity utilization of 56%, up from 52% in Q2 2025.

• Net debt was C$2.3M at June 30, 2026, C$0.4M lower than the prior-year comparison.

• Q2 2026 delivered record patient visits; six physicians started in Q3 2026.

Market and growth priorities

• Chronic pain affects 1 in 5 Canadian adults and 1 in 3 people over age 65; the provider market is fragmented, with opportunities to expand services and enter additional markets.

• Growth priorities include adding physician hours, expanding in Guelph, broadening services through Arthrosamid training and assessing selective acquisitions.

• Physician recruitment, rostered physicians adding time and technology investment are intended to increase available hours within existing clinics.

• Physician support includes referral access, modern equipment, technology, professional facility staff, learning programs and back-office services.